Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: IRADIMED CORPORATION

Market Cap 1.23B 1.07B 984M 922M 1.72B 118B 1.76B 11.74B 4.55B 56.79B 4.62B 4.52B 197B P/E Ratio 2026 *
50.4x
P/E Ratio 2027 * 44.5x
Enterprise Value 1.23B 1.07B 984M 922M 1.72B 118B 1.76B 11.74B 4.55B 56.79B 4.62B 4.52B 197B EV / Sales 2026 *
13.5x
EV / Sales 2027 * 12.2x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.51%
1 week+2.47%
Current month+5.20%
1 month+12.53%
3 months-4.03%
6 months-0.89%
Current year-1.96%
1 week 93.11
Extreme 93.11
98.41
1 month 83.85
Extreme 83.85
98.41
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 2020-05-27
Director of Finance/CFO 64 2022-06-19
Chief Tech/Sci/R&D Officer - 2019-12-31
Director TitleAgeSince
Chairman 72 2020-06-15
Director/Board Member 70 2018-12-31
Director/Board Member 73 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
05-26Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-1.51%+2.47%+60.12%+100.65% 1.23B
+1.60%+2.19%-13.74%-16.65% 13.58B
-5.68%-15.65%+71.11%+6.23% 5.18B
+3.68%+1.18%-40.68%-67.42% 1.21B
+1.85%-5.55%-35.69%-42.75% 1.18B
+5.99%+0.39%-38.96% - 928M
+0.47%-7.20%+188.95%+182.62% 712M
+5.59%+1.67% - - 344M
+4.26%+7.45%-57.99%+201.67% 235M
+3.70%-0.22%-23.74%-48.06% 146M
Average +2.00%-1.23%+12.15%+39.54% 2.47B
Weighted average by Cap. +0.26%-1.39%+10.07%-1.34%

Financials

2026 *2027 *
Net sales 91.2M 79.14M 72.95M 68.36M 128M 8.73B 130M 870M 337M 4.21B 342M 335M 14.64B 101M 87.56M 80.71M 75.63M 141M 9.66B 144M 963M 373M 4.66B 379M 371M 16.19B
Net income 24.55M 21.3M 19.64M 18.4M 34.38M 2.35B 35.1M 234M 90.7M 1.13B 92.16M 90.17M 3.94B 27.8M 24.12M 22.24M 20.84M 38.93M 2.66B 39.74M 265M 103M 1.28B 104M 102M 4.46B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
Employees
166
Date Price Change Volume
26-06-12 95.37 $ -0.92% 95,681
26-06-11 96.26 $ +0.27% 155,741
26-06-10 96.00 $ -0.44% 153,648
26-06-09 96.42 $ +2.15% 154,712
26-06-08 94.39 $ +1.42% 93,412
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
96.26USD
Average target price
118.00USD
Spread / Average Target
+22.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!